Biohaven Ltd.
BHVN
NYSE
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | -144.76M | -102.57M | -90.35M | -70.49M | -201.11M |
Total Depreciation and Amortization | 1.89M | 1.54M | 1.83M | 1.65M | 344.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 36.70M | 3.44M | 2.76M | 2.02M | 126.36M |
Change in Net Operating Assets | -8.72M | 2.78M | 41.36M | -10.81M | -999.00K |
Cash from Operations | -114.88M | -94.81M | -44.39M | -77.64M | -75.41M |
Capital Expenditure | -470.00K | -1.25M | -595.00K | -735.00K | -300.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -3.44M | 59.80M | 76.85M | -324.00K | -263.72M |
Cash from Investing | -3.91M | 58.55M | 76.25M | -1.06M | -264.02M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 247.92M | -- | -- | -- | 284.26M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -2.69M | -39.66M | -20.34M | 26.67M | 245.93M |
Cash from Financing | 245.24M | -39.66M | -20.34M | 26.67M | 530.18M |
Foreign Exchange rate Adjustments | -310.00K | -40.00K | -162.00K | 15.00K | 429.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 126.13M | -75.96M | 11.36M | -52.01M | 191.19M |